Intravenous administration of hUCB-MSCs did not affect the density of CD68+ total macrophages but significantly increased macrophages expressing CD206, a marker of M2 macrophages, in RDEB skin at day 56 (Figure 5). The gene discussed is MRC1; the disease is recessive dystrophic epidermolysis bullosa.